Keyphrases
Meta-analysis
100%
Systematic Meta-analysis
100%
Adjuvant Therapy
100%
Pemphigus
100%
Remission
66%
Disease Control
66%
Relapse Risk
66%
Oral Glucocorticoids
66%
Confidence Interval
33%
Intravenous Immunoglobulin (IVIg)
33%
Randomized Controlled Trial
33%
Cyclosporine
33%
Relative Risk
33%
All-cause Mortality
33%
Adverse Events
33%
Risk Reduction
33%
Plasma Exchange
33%
Meta-analysis of Randomized Controlled Trials
33%
Mycophenolate Mofetil
33%
Infliximab
33%
Pemphigus Vulgaris
33%
Glucocorticoid Therapy
33%
Cyclophosphamide
33%
Pemphigus Foliaceus
33%
Time to Relapse
33%
Cumulative Glucocorticoid Dose
33%
Relapse Time
33%
Control Time
33%
Medicine and Dentistry
Systematic Review
100%
Meta-Analysis
100%
Adjuvant Therapy
100%
Adjuvant
100%
Pemphigus
100%
Glucocorticoid
60%
Disease
40%
Randomized Controlled Trial
40%
Immunoglobulin
20%
Adverse Event
20%
Cause of Death
20%
Cyclosporine
20%
Mycophenolic Acid
20%
Pemphigus vulgaris
20%
Cyclophosphamide
20%
Infliximab
20%
Azathioprine
20%
Plasma Exchange
20%
Pemphigus foliaceus
20%
Pharmacology, Toxicology and Pharmaceutical Science
Adjuvant
100%
Pemphigus
100%
Glucocorticoid
60%
Disease
40%
Randomized Controlled Trial
40%
Remission
40%
Adverse Event
20%
Cause of Death
20%
Immunoglobulin
20%
Infliximab
20%
Ciclosporin
20%
Pemphigus vulgaris
20%
Cyclophosphamide
20%
Mycophenolic Acid
20%
Azathioprine
20%
Pemphigus foliaceus
20%
Immunology and Microbiology
Pemphigus
100%
Adjuvant
100%
Glucocorticoid
60%
Intravenous Immunoglobulin
20%
Blood Plasma
20%
Ciclosporin
20%
Infliximab
20%
Cyclophosphamide
20%
Azathioprine
20%
Mycophenolic Acid
20%
Pemphigus vulgaris
20%
Pemphigus foliaceus
20%